{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04267640: Phase 2 Interventional Unknown status Peripheral Artery Disease
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04380701: Phase 1/Phase 2 Interventional Completed Infections, Respiratory
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:zorecimeran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03263611: Phase 1 Interventional Completed Degenerative Disc Disease
(2018)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:vibosameran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03165864: Phase 1 Interventional Completed Thalassemia
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00512083: Phase 2 Interventional Completed Leukemia, Myeloid
(2007)
Source URL:
Class:
NUCLEIC ACID